1. Home
  2. THRD vs NWFL Comparison

THRD vs NWFL Comparison

Compare THRD & NWFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • NWFL
  • Stock Information
  • Founded
  • THRD 2019
  • NWFL 1870
  • Country
  • THRD United States
  • NWFL United States
  • Employees
  • THRD N/A
  • NWFL N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • NWFL Major Banks
  • Sector
  • THRD Health Care
  • NWFL Finance
  • Exchange
  • THRD Nasdaq
  • NWFL Nasdaq
  • Market Cap
  • THRD 164.2M
  • NWFL 180.0M
  • IPO Year
  • THRD 2022
  • NWFL 1998
  • Fundamental
  • Price
  • THRD $5.14
  • NWFL $24.39
  • Analyst Decision
  • THRD Hold
  • NWFL Buy
  • Analyst Count
  • THRD 3
  • NWFL 3
  • Target Price
  • THRD $5.00
  • NWFL $28.17
  • AVG Volume (30 Days)
  • THRD 1.2M
  • NWFL 30.8K
  • Earning Date
  • THRD 05-14-2025
  • NWFL 04-17-2025
  • Dividend Yield
  • THRD N/A
  • NWFL 5.25%
  • EPS Growth
  • THRD N/A
  • NWFL N/A
  • EPS
  • THRD N/A
  • NWFL 0.14
  • Revenue
  • THRD N/A
  • NWFL $50,378,000.00
  • Revenue This Year
  • THRD N/A
  • NWFL $78.94
  • Revenue Next Year
  • THRD N/A
  • NWFL $7.21
  • P/E Ratio
  • THRD N/A
  • NWFL $167.89
  • Revenue Growth
  • THRD N/A
  • NWFL N/A
  • 52 Week Low
  • THRD $3.18
  • NWFL $21.25
  • 52 Week High
  • THRD $16.94
  • NWFL $34.50
  • Technical
  • Relative Strength Index (RSI)
  • THRD 79.10
  • NWFL 55.31
  • Support Level
  • THRD $5.08
  • NWFL $22.25
  • Resistance Level
  • THRD $5.20
  • NWFL $25.05
  • Average True Range (ATR)
  • THRD 0.11
  • NWFL 1.02
  • MACD
  • THRD 0.13
  • NWFL 0.33
  • Stochastic Oscillator
  • THRD 96.84
  • NWFL 82.63

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About NWFL Norwood Financial Corp.

Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.

Share on Social Networks: